Hemopure blood substitute 156 units
Ended Purchase Order Awarded
- Contract number
- FA301616P0226
- Awardee
-
Hemoglobin Oxygen Therapeutics LLC UEI UJAMF5FC81N9
- Awarding agency
-
Air Education and Training Command
Air Force, Department of Defense
- Obligated
- $110,760
Award facts
- Contract value 100% obligated
- $110,760.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Souderton, PA 18964, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price purchase order awarded by the Air Education and Training Command, a defense agency, to Hemoglobin Oxygen Therapeutics LLC for the delivery of 156 units of HEMOPURE blood substitute. The contract has a ceiling value of $110,760.00 and an ultimate completion date of August 10, 2016. No set-aside designation was used for this award. Hemoglobin Oxygen Therapeutics LLC is the prime contractor, and there are no major subcontractors mentioned.
Quick answers
Who was awarded contract FA301616P0226?
FA301616P0226 was awarded to Hemoglobin Oxygen Therapeutics LLC by Air Education and Training Command (Air Force) on August 1, 2016.
How much is contract FA301616P0226 worth?
The government has obligated $110,760 on FA301616P0226.
Was contract FA301616P0226 competed?
The extent of competition for FA301616P0226 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award